Abstract
The last decade or two have witnessed a sharp and steady increase in research and interest in the affective disorders. Clinically, major depressive illness has been delineated from other psychiatric disorders with depressed mood and clinical subtypes of depression have been proposed to reflect the heterogeneity among subgroups of depression. In addition to descriptive and clinical criteria, subtypes of depression have also been differentiated by biological markers such as sleep electroencephalography (EEG) records (1), urinary 3-methoxy-4-hydroxy phenylglycol (MHPG) excretion (2), cerebrospinal fluid 5-hydroxyindol acetic acid (HIAA) concentrations (3) and the dexamethasone suppression test (DST) (4). Particularly relevant to the theme of this book are studies in neuroendocrine and immune regulation in depression. In this chapter we will first summarize major advances in the study of hypothalamic-pituitary-adrenal (HPA) axis activity in the depressive disorders, then review some of the preliminary work in the immunology of depression.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
D. Kupfer, G. Foster, P. Coble, R. McPartland and R. Ulrich, The application of sleep EEG for the differential diagnosis of affective disorders. Am J Psychiatry, 135: 69 (1978).
J. Fawcett, J.W. Maas and H. Dekirmemjian, Depression and MHPG excretion: Responses to dextroamphetamine and tricyclic antidepressants. Arch Gen Psychiatry, 26: 246 (1972).
M. Asberg, P. Thoren, L. Traskman, L. Bertillson and V. Ringberger, Serotonin depression - a biochemical subgroup within the affective disorders? Science, 191: 478 (1976).
B.J. Carroll, M. Feinberg, J. Greden, J. Tarika, A. Albala, R. Haskett, N. James, Z. Kronfol, N. Lohr, M. Steiner, J.P. deVigne and E. Young, A specific laboratory test for the diagnosis of melancholia: standardization, validation and clinical utility. Arch Gen Psychiatry, 38: 15 (1981).
B.J. Carroll and J. Mendels, Neuroendocrine regulation in affective disorders. in: “Hormones, Behavior and Psychopathology”, E.J. Sachar, ed., Raven Press, New York (1976).
B.J. Carroll, The dexamethasone suppression test for melancholia. Br J Psychiatry, 140: 292 (1982).
F. Board, R. Wadeson and H. Persky, Depressive affect and endocrine functions. Arch Neurol Psychiatry, 78: 612 (1957).
E.J. Sachar, L. Hellman, D.K. Fukushima and T.F. Gallagher, Cortisol production in depressive illness. Arch Gen Psychiatry, 23: 289 (1970).
B.J. Carroll, G.C. Curtis, B.M. Davies, J. Mendels and A.A. Sugerman, Urinary free cortisol excretion in depression. Psychol Med, 6: 43 (1976).
B.J. Carroll, G.C. Curtis and J. Mendels, Cerebrospinal fluid and plasma free cortisol concentrations in depression. Psychol Med, 6: 235 (1976).
J.L. Gibbons, Cortisol secretion rate in depressive illness. Arch Gen Psychiatry, 10: 572 (1964).
E.J. Sachar, L. Hellman, H. Roffwarg, F. Halpern, D. Fukushima and T. Gallagher, Disrupted 24-hour patterns of cortisol secretion in psychotic depression. Arch Gen Psychiatry, 28: 19 (1973).
F.H. Tyler and C.D. West, Laboratory evaluation of disorders of the adrenal cortex. Am J Med, 53: 664 (1972).
H.C. Ferguson, A.C.G. Bartram, H.C. Fowlie, D.M. Cathro, K. Birchall and F.L. Mitchell, A preliminary investigation of steroid excretion in depressed patients before and after electroconvulsive therapy. Acta Endocrinol, 47: 58 (1964).
J. Schlechte, B. Sherman and B. Pfohl, A comparison of adrenal corticol function in patients with depression and patients with Cushing’s disease. (submitted).
S. Berson and R. Yalow, Radioimmunoassay of ACTH in plasma. J Clin Invest, 47: 2725 (1968).
J.P. Allen, D. Denney, J. Kendall and P.H. Blachly, Corticotropin release during ECT in man. Am J Psychiatry, 131: 1225 (1974).
V.S. Fang,B.J. Tricou, A. Robertson and H.Y. Meltzer, Plasma ACTH and cortisol levels in depressed patients: Relation to dexamethasone suppression test. Life Sci, 29:931 (1981).
B.I. Yerevanian, P.D. Woolf and H.P. Idel, Plasma ACTH levels in depression before and after recovery: Relationship to the dexamethasone suppression test. Psychiatry Res, 9: 45 (1983).
V.I. Reus, M.S. Joseph and M.F. Dallman, M.F. ACTH levels after the dexamethasone suppression test in depression. N Engl J Med, 306: 238 (1982).
N.H. Kalin, S.J. Weiler and S.E. Shelton, Plasma ACTH and cortisol concentrations before and after dexamethasone. Psychiatry Res, 7: 87 (1982).
B. Pfohl, B. Sherman and J. Schlechte, Differences in plasma ACTH and cortisol between depressed patients and normal controls. Biol Psychiatry, in press.
B. Pfohl, B, Sherman and J. Schlechte, Pituitary-adrenal axis rhythm disturbances in major depression. Arch Gen Psychiatry, in press.
W. Vale, J. Spiess, C. Rivier and J. Rivier, Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science, 213: 1394 (1982).
P.W. Gold, G. Chrousos, C. Kellner, R. Post, A. Roy, P. Augerinos, H. Schulte, E. Oldfield and L. Lorianx, Psychiatric implications of basic and clinical studies with corticotrophin releasing factor. Am J Psychiatry, 141: 619 (1984).
R. Guillemin, T. Vargo and J. Rossier, Beta-endorphin and ACTH are secreted concomitantly by the pituitary gland. Science, 197: 1367 (1977).
G.S. Alexopoulos, C.E. Inturrisi, R. Lipman, R. Frances, J. Haycox, J.H. Dougherty, Plasma immunoreactive beta-endorphin levels in depression. Arch Gen Psychiatry, 40: 181 (1983).
F. Brambilla, A.R. Genazzani, F. Facchinetti, D. Parrin, F. Petraglia, E. Sacchetti, S. Scarone, A. Guastalla and N. d’Antona, Beta-endorphin and beta-lipotropin plasma levels in chronic schizophrenia, primary affective disorders and secondary affective disorders. Psychoneuroendocrinoloy, 6: 321 (1981).
S.C. Risch, Beta-endorphin hypersecretion in depression: possible cholinergic mechanisms. Biol Psychiatry, 17: 1071 (1982).
M.R. Cohen, D. Pickar, I. Exstein, M. Gold and D. Sweeney, Plasma cortisol and beta-endorphin immunoreactivity in nonmajor and major depression. Am J Psychiatry, 141: 628 (1984).
D. Pickar, N.R. Cutler, D. Naber, R. Post, C. Pert and W. Bunney, Plasma opioid activity in manic-depressive illness. Lancet, 1: 937 (1980).
D. Pickar, M.R. Cohen, D. Naber and R.M. Cohen, Clinical studies of the endogenous opioid system. Biol Psychiatry, 17: 1243 (1982).
L. Terenius, A. Wahlstrom and H. Agren, Naloxone (Narcan) treatment in depression: clinical observations and effects of CSF endorphins and monoamine metabolites. Psychopharmacology, 54: 31 (1977).
J. Angst, V. Autenrieth, F. Brem, M. Koukkou, H. Meyer, H. H. Stassen and U. Storck, Preliminary results of treatment with beta-endorphin in depression. in: “Endorphins in Mental Health Research”, E. Usdin, W. Bunney and N. Kline, eds., Oxford University Préss, New York (1979).
R.B. Shekelle, W.J. Raynor, A.M. Ostfeld, D.C. Garron, L.A. Bieliauskas, C.L. Shuguey, C. Maliza and P. Ogelsby, Psychological depression and 17-year risk of death from cancer. Psychosom Med, 43: 117 (1981).
M. Rogers, D. Dubey and P. Reich, The influence of the psyche and the brain on immunity and disease susceptibility: A critical review. Psychosom Med, 41: 147 (1979).
M. Stein, S. Schleifer and S. Keller, Immune disorders, in: “Comprehensive Textbook of Psychiatry”, Third Edition, H Kaplan, A. Freedman and B. Sadock, eds., Williams and Wilkins, Baltimore, (1980).
J. Palmblad, K. Cantell, H. Strander, J. Froberg, C. Karlsson, L. Levi, M. Granstrom and P. Ungar, Stressor exposure and immunological response in man: interferon-producing capacity and phagocytosis. J Psychom Res, 20: 193 (1976).
J. Palmblad, B. Petrini, J. Wasserman and T. Akerstedt, Lymphocyte and granulocyte reactions during sleep deprivation. Psychosom Med, 41: 273 (1979).
B. Dorian, D. Garfinkel, G. Brown, A. Shore, D. Gladman and E. Keystone, Aberrations in lymphocyte subpopulations and function during psychological stress. Clin Exp Immunol, 50: 132 (1982).
J. Jemmott, J. Borysenko, M. Borysenko, D. McClelland, R. Chapman and D. Meyer, Academic stress, power motivation and decrease in secretion rate of salivary secretory immunoglobulin A. Lancet, I: 1400 (1983).
J. Kiecolt-Glaser, W. Garner, C. Speicher, G. Penn, J. Holliday and R. Glaser, Psychosocial modifiers of immunocompetence in medical students. Psychosom Med, 46: 7 (1984).
S. Locke, M. Hurst and J. Heisel, J. The influence of stress on the immune response. Annual Meeting, American Psychosomatic Society, Washington, D.C. (1978).
G.H. Baker, N. Byrom, M. Irani, D. Brewerton, J.R. Hobbs, R.J. Woods and M. Nagvekar, Stress, cortisol and lymphocyte subpopulations. Lancet, I: 574 (1984).
R. Bartrop, L. Lazarus, D. Luckhurst and L. Kiloh, Depressed lymphocyte function after bereavement. Lancet, I: 834 (1977).
S. Schleifer, S. Keller, M. Camerino, J. Thornton and M. Stein, Suppression of lymphocyte stimulation following bereavement. J Am Med Assoc, 250: 374 (1983).
Z. Kronfol, Depression and immune disease. Psychiatr Med, (in press).
Z. Kronfol, Cancer and depression. Br J Psychiatry, 142: 309 (1983).
H. vonBrauchitsch, Antinuclear factor in psychiatric disorders. Am J Psychiatry, 128: 1552 (1972).
R. Deberdt, J. VanHooren, M. Biesbrouch and W. Amery, Antinuclear factor-positive mental depression: A single disease entity? Biol Psychiatry, II: 69 (1976).
F. Plantey, Antinuclear factor in affective disorders. Biol Psychiatry, 13: 149 (1978).
E. Johnstone and K. Whaley, Antinuclear antibodies in psychiatric illness: their relationship to diagnosis and drug treatment. Br Med J, 2: 724 (1975).
R. Rimon, P. Halonin, E. Anttinen and E. Evola, Complement fixing antibody to herpes simplex virus in patients with psychotic depression. Dis Nery Sys, 32: 822 (1971).
R. Coppel, F. Gregoire, L. Thiry and S. Sprecher, Antibody and cell-mediated immunity to herpes simplex virus in psychotic depression. J Clin Psychiatry, 39: 266 (1978).
D. Sengar, B. Waters and J. Dunne, J. Lymphocyte subpopulations and mitogenic responses of lymphocytes in manic depressive disorder. Biol Psychiatry, 17: 1017 (1982).
Z. Kronfol, J. Silva, J. Greden, S. Dembinski, R. Gardner and B.J. Carroll, Impaired lymphocyte function in depressive illness. Life Sci, 33: 241 (1983).
S. Schleifer,SS. Keller, A. Meyerson, M. Raskin, K. Davis and M. Stein, Lymphocyte function in major depressive disorder. Arch Gen Psychiatry, 41: 484 (1984).
Z. Kronfol and J.D. House, Depression, cortisol and immune function. Lancet, I: 1026 (1984).
H. Nasrallah, Z. Ballas, Z. Kronfol and S. Chapman, Natural-killer cell activity in major depression. in: “Viruses, Immunity and Mental Diseases”, E. Kurstak, ed., Plenum Press, New York, (in press).
C. Van Dyke, K. McDaniel, V. Reus, W. Seaman and C. Kaufman, Immune response in depressed and Cushing’s patients. American Psychiatric Association Annual Meeting, New Research Abstract #42, Los Angeles, CA (1984).
Z. Kronfol, R. Turner, H. Nasrallah and G. Winokur, Leukocyte regulation in depression and schizophrenia. Psychiatry Res, 13: 13 (1984).
Z. Kronfol, H. Nasrallah, S. Chapman and J.D. House, Depression, cortisol metabolism and lymphocytopenia. J Affect Disord, (in press).
Z. Kronfol, J.D. House, J. Greden and B.J. Carroll, Depression, urinary free cortisol excretion and lymphocyte function. Br J Psychiatry, (in press).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kronfol, Z., Schlechte, J. (1986). Depression, Hormones and Immunity. In: Plotnikoff, N.P., Faith, R.E., Murgo, A.J., Good, R.A. (eds) Enkephalins and Endorphins. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0557-4_7
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0557-4_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0559-8
Online ISBN: 978-1-4899-0557-4
eBook Packages: Springer Book Archive